UCM710
UCM710 is an endocannabinoid (eCB) hydrolysis inhibitor that increases the levels of N-arachidonoyl ethanolamine and 2-arachidonoylglycerol in neurons. UCM710 inhibits fatty acid amide hydrolase and α/β-hydrolase domain 6, but not monoacylglycerol lipase[1].
Product Specifications
CAS Number
213738-77-3
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/ucm710.html
Solubility
10 mM in DMSO
Smiles
CCCCCC/C=C\CCCCCCCC(OCC1OC1)=O
Molecular Formula
C19H34O3
Molecular Weight
310.47
References & Citations
[1]Marrs WR, et al. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. J Biol Chem. 2011 Aug 19;286 (33) :28723-28728.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV626019 1.0 µg DNA
SLC24A3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 
134834-FITC 100 µL
TSSK1B (Testis-specific Serine/threonine-protein Kinase 1, TSSK1, TSSK-1, Testis-specific Kinase 1, TSK1, TSK-1, FKSG81, Serine/threonine-protein Kinase 22A, STK22A, SPOGA1, SPOGA4, STK22D) (FITC)
Sign In for Pricing
View Details